del Villar GK, Vásquez CS, García MR, Tafoya RF, Aragón ML, Valencia MN

Language: Spanish
References: 20
Page: 84-88
PDF size: 321.75 Kb.

ABSTRACT

Cervical cancer is the leading cause of death from malignancy in women and the second leading cause of malignancy in the world, in Mexico, in 2003, is first in incidence. The evidence indicates that 98% of these tumors are caused by infection of the human papilloma virus; of the 100 genotypes, 20 infect the cervix, high-risk genotypes are 16 and 18 in Mexican women, which are almost 80% of all cases of cervical cancer. This cancer is the most common gynecologic entity in Mexico (34.2%), the leading cause of death in women, and occurs most often between 30 and 40 years old. It is very important to identify premalignant lesions, since the outcome depends on how advanced the disease is at diagnosis. Colposcopy has a significant impact on the management of abnormal Pap results.

REFERENCES

1. Hinojosa LM. Lesiones preinvasoras del cuello uterino. Manual de Oncología del Instituto Nacional de Cancerología, 4a ed. pp. 731-758.

2. Maisanava J, Muniesa J. Citología exfoliativa cervicovaginal (método de Papanicolaou), Boletín Oncológico del Hospital Obispo Polanco Teruel.

3. RHNM. Registro Histopatológico de Neoplasias Malignas 2001.

4. Ferlay J, Bray F, Pisani P, Parkin DM.GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No 5, version 2.0. Lyon, France: IARC. Press. 2004.

5. García AS. Sistema Bethesda. Nueva nomenclatura en el informe de la citología cervicovaginal. Boletín de Epidemiología del Cáncer Cervicouterino en el Instituto Mexicano del Seguro Social, 1998; 3 (VII): 1-4.

6. Pisani P et al. Cancer and infection: estimate of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev. 1997; 6 (6): 387-400.

7. Hernández B. Clínica de displasias. Manual de Normas y Procedimientos México. Hospital Regional 1° de Octubre ISSSTE, 2000.

8. Richard RM. Natural history of cervical intraepithelial neoplasia. Clin Obstet Gynecol. 1967; 10: 748-784.

9. Reagan JW, Seidemann IL, Saracusa Y. Cellular morphology of carcinoma in situ and dysplasia or atypical hyperplasia of uterine cervix. Cancer. 1953; 6: 224-235.

10. Poulsen HE et al. Histological typing of genital tract tumours. International histological classification of tumours. No. 13, Génova, World Health Organization, 1977.

11. Alcalá PF. Cáncer cervicouterino. Manual de Oncología del Instituto Nacional de Cancerología, 2ª ed. pp. 506-521.

12. Spitzer M, Ryskin M. The value of repeat pap smear at the time of initial colposcopy. Gynecol Oncol. 1998; 69 (3): 269-270.

13. Solomon D et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002; 287 (16): 2114-2119.

14. Koigi-Kamau R. Impact of colposcopy on management outcomes of patients with abnormal cervical cytology. East Afr Med J. 2007; 84 (3): 110-116.

15. Massad LS. Correlating Papanicolaou smear, colposcopic impression, and biopsy: results from de women’s interagency HIV study. J Low Genit Tract Dis. 2001; 5 (4): 212-218.

16. Tuon FF. Sensibility and specificity of cytology and colposcopy exams with the histological evaluation of cervical intraepithelial lesions. Rev Assoc Med Bras. 2002; 48 (2): 140-144.

17. Panozo MW. La biopsia como estándar de oro para determinar la discrepancia entre la citología y la colposcopia, en displasias y cáncer de cuello uterino. Revista Médica, Órgano Oficial del Colegio Médico de La Paz. 2005; 11 (2): 29-40.

18. NOM 014 SSA2-1994. Para prevención, detección, diagnóstico, tratamiento, control y vigilancia epidemiológica del cáncer cervicouterino. Diario Oficial de la Federación publicado el 31 de mayo de 2007.

19. Rita Sotelo-Regil Hallmann. Correlación citohistológica en el Instituto Nacional de Cancerología en el año 2006. Patología. 2008; 46 (4): 309-314.

20. Muñoz N, Bosch X, Kaldor JM. Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. Br J Cancer. 1988; 57: 1-5.